Parallelized sample processing and library prep
US-12097501-B2 · Sep 24, 2024 · US
US2016195535A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016195535-A1 |
| Application number | US-201314653562-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 18, 2013 |
| Priority date | Dec 20, 2012 |
| Publication date | Jul 7, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The purpose of the present invention is to provide a method for detecting prostatic basal cells by searching for molecules that are expressed specifically in prostatic basal cells and analyzing said molecules. The problem can be solved using a method for detecting prostatic basal cells that is characterized by using immunohistochemical staining to visualize the expression of TRIM29 (Tripartite motif-containing protein 29) protein in prostatic basal cells.
Opening claim text (preview).
1 . A method for detecting prostatic basal cells, comprising visualizing the expression of tripartite motif-containing protein 29 (TRIM29) protein in basal cells of a prostate by immunohistostaining. 2 . The method for detecting prostatic basal cells according to claim 1 , comprising analyzing the morphology of the glandular tissue structure of the prostate and the visualized expression of tripartite motif-containing protein 29 (TRIM29) protein. 3 . The method for detecting prostatic basal cells according to claim 1 , further comprising visualizing the expression of cytokeratin and/or p63 protein by immunohistostaining. 4 . The method for detecting prostatic basal cells according to claim 3 , comprising analyzing the morphology of the glandular tissue structure of the prostate and the visualized expression of cytokeratin protein and/or the visualized expression of p63 protein. 5 . A method for identifying the presence, decrease, or disappearance of prostatic basal cells, comprising using the method for detecting prostatic basal cells according to claim 1 . 6 . A method for diagnosing prostate cancer, comprising a step of detecting prostatic basal cells in prostate tissue collected from a subject by immunohistostaining using an anti-TRIM29 antibody or an antigen-binding fragment thereof. 7 . The diagnostic method according to claim 6 , wherein the decrease or disappearance of prostatic basal cells as compared to those in normal prostate tissue indicates the presence of prostate cancer. 8 - 10 . (canceled) 11 . An immunohistostaining kit for detecting prostatic basal cells, comprising an anti-TRIM29 antibody or an antigen-binding fragment thereof. 12 . The immunohistostaining kit for detecting prostatic basal cells according to claim 11 , further comprising an anti-cytokeratin antibody or an antigen-binding fragment thereof and/or an anti-p63 antibody or an antigen-binding fragment thereof.
of the prostate · CPC title
Regulators; Modulating activity · CPC title
Keratin; Cytokeratin · CPC title
Physics · mapped topic
against material from animals or humans · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.